Possible use of micrornas as biomarkers for momtorisg of workers exposed to asbesto;Possibile impiego di microRNA come biomarcatori nel monitoraggio dei lavoratori professionalmente esposti ad amianto

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 34, Issue 3, 2012, Pages 571-573

  Sturchio, E ^a   Amadori, A ^b   Businaro, J ^c   Ficociello, B ^a   Ferrazza, P ^b   Colosio, C ^d   Minoia, C ^c  

^a ISPESL   (Italy)

^b LN Age srl   (Italy)

^c IRCCS   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Asbestos exposure; Diagnostic biomarkers and prognostic factors; Mesothelioma; MicroRNAs

Indexed keywords

ASBESTOS; BIOLOGICAL MARKER; MICRORNA;

ARTICLE; ENVIRONMENTAL MONITORING; HUMAN; METHODOLOGY; OCCUPATIONAL EXPOSURE;

ASBESTOS; BIOLOGICAL MARKERS; ENVIRONMENTAL MONITORING; HUMANS; MICRORNAS; OCCUPATIONAL EXPOSURE;

EID: 84868334066     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Robinson, B.W., and Lake, R. A. Advances in malignant mesothelioma. N. Engl. J. Med. 2005; 353: 1591-1603.
2. Marinaccio, A., Binazzi, A., Marzio, D.D., et al. and ReNaM Working Group. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int. J. Cancer. 2011; 1; 130(9): 2146-54.
3. Nymark, P., Wikman H., Hienonen-Kempas T., Anttila, S. Molecular and genetic changes in asbestos-related lung cancer. Cancer Letters 2008;265: 1-15.
4. De Melo M, Gerbase MW, Curran J, Pache JC. Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma. J Histochem Cytochem 2006; 54:855-861.
5. Cragg MS, Jansen ES, Cook M, Harris C, Strasser A, Scott CL. Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic. J Clin Invest 2008; 118:3651-3659.
6. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, et al. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 2006; 34:524-533.
7. Younes MN, Kim S, Yigitbasi OG, et al. Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 2005; 4: 1146-1156.
8. Batra S, Shi Y, Kuchenbecker KM, et al. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun. 2006; 342 (4): 1228-1232.
9. Christensen BC, Houseman EA, Godleski JJ, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res. 2009;69(1):227-234.
10. Goto Y, Shinjo K, Kondo Y, et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res. 2009;69(23):9073-9082.
11. Christensen, B.C., Godleski, J.J., Marsit, C.J., et al. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma, Carcinogenesis 2008;29: 1555-1559.
12. Griffiths-Jones, S., Grocock, R.J., van Dongen, S. et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34 (Database issue), D140-4.
13. Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer Gene Ther 2010; 17:523-531.
14. Gee GV, Koestler DC, Christensen BC, et al. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer 2010; 127:2859-2869.
15. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10: 593-601.
16. Benjamin H, Lebanony D, Rosenwald S, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010; 12: 771-779.
17. * is Linked to the Prognosis of MalignantPIeural Mesothelioma. Cancer Res 2010;70:1916-1924.
18. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.